With money flowing into Bio's ISN looms to be positioned very well. Revenue in excess of $10m for 2013.
http://www.isoneamed.com/rbmilestone.pdf
Management been upgrading forecasts in recent pressos
http://www.asx.com.au/asxpdf/20120111/pdf/423q06bpf43kyk.pdf
Good times ahead for this up and coming Bio.
Add to My Watchlist
What is My Watchlist?